378 related articles for article (PubMed ID: 29435777)
1. Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
Tseng AS; Patel RD; Quist HE; Kekic A; Maddux JT; Grilli CB; Shamoun FE
Cardiovasc Drugs Ther; 2018 Feb; 32(1):121-126. PubMed ID: 29435777
[TBL] [Abstract][Full Text] [Related]
2. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
3. Warfarin Pharmacogenomics in Diverse Populations.
Kaye JB; Schultz LE; Steiner HE; Kittles RA; Cavallari LH; Karnes JH
Pharmacotherapy; 2017 Sep; 37(9):1150-1163. PubMed ID: 28672100
[TBL] [Abstract][Full Text] [Related]
4. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
5. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants.
Cullell N; Carrera C; Muiño E; Torres N; Krupinski J; Fernandez-Cadenas I
Oncotarget; 2018 Jun; 9(49):29238-29258. PubMed ID: 30018749
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
Hum J; Shatzel JJ; Jou JH; Deloughery TG
Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
[TBL] [Abstract][Full Text] [Related]
8. Use of Pharmacogenomics to Guide Proton Pump Inhibitor Therapy in Clinical Practice.
Harris DM; Stancampiano FF; Burton MC; Moyer AM; Schuh MJ; Valery JR; Bi Y
Dig Dis Sci; 2021 Dec; 66(12):4120-4127. PubMed ID: 33475867
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).
O'connor CT; Kiernan TJ; Yan BP
Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):725-739. PubMed ID: 28571507
[TBL] [Abstract][Full Text] [Related]
10. Prenatal pharmacogenomics: a promising area for research.
Dorfman EH; Cheng EY; Hebert MF; Thummel KE; Burke W
Pharmacogenomics J; 2016 Aug; 16(4):303-4. PubMed ID: 27168097
[TBL] [Abstract][Full Text] [Related]
11. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
[TBL] [Abstract][Full Text] [Related]
12. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal bleeding secondary to the new anticoagulants.
Abraham NS; Horsley-Silva JL
Curr Opin Gastroenterol; 2016 Nov; 32(6):474-480. PubMed ID: 27636303
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics and the management of oral anticoagulation.
Wittkowsky AK
Curr Hematol Rep; 2004 Sep; 3(5):363-7. PubMed ID: 15341704
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic evaluation of warfarin pharmacogenomics.
You JH
Expert Opin Pharmacother; 2011 Feb; 12(3):435-41. PubMed ID: 21231897
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.
Shu WY; Li JL; Wang XD; Huang M
Acta Pharmacol Sin; 2015 May; 36(5):535-43. PubMed ID: 25891088
[TBL] [Abstract][Full Text] [Related]
17. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).
Hakeam HA; Al-Sanea N
J Thromb Thrombolysis; 2017 Apr; 43(3):343-351. PubMed ID: 28050755
[TBL] [Abstract][Full Text] [Related]
18. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
[TBL] [Abstract][Full Text] [Related]
19. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
20. [Direct oral anticoagulants (DOAC) in tumor patients].
Trappe RU; Sinn M; Riess H
Dtsch Med Wochenschr; 2016 Sep; 141(20):1446-1450. PubMed ID: 27701688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
